Clinical Trial Update: Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial

View source ↗

Summary

The ACTIN trial investigating aging biomarkers and contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Sun Yat-sen University | Conditions: Contrast Induced Nephropathy | Status: COMPLETED